Skip to main content

Aaron Wealth Advisors

SEC CIK
0001812198
Latest filing
Jul 16, 2026

LPCN holding history

Lipocine Inc. in every 13F filed by Aaron Wealth Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LPCN overviewAll 13F holders of LPCNFull Q2 2026 holdings

Shares (Q2 2023)
0
Sold out in Q2 2023
Value
$0
% of portfolio
0.0%
Quarters held
6
Since Q1 2021
Holdings of LPCN by Aaron Wealth Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20230$00.0%−2,115−100.0%Sold outConverted for a 1-for-17 splitHolders
Q1 202335,949$11.4K<0.1%00.0%UnchangedHolders
Q4 202235,949$13.8K<0.1%−9,096−20.2%ReducedHolders
Q3 202245,045$20.0K<0.1%−100,000−68.9%ReducedHolders
Q2 2022145,045$116.0K<0.1%+27,493+23.4%AddedHolders
Q1 2022117,552––+117,552NewHolders
Q2 20210$00.0%−15,000−100.0%Sold outHolders
Q1 202115,000$22.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.